Women who take Zofran to control morning sickness or hyperemesis gravidarum during their first trimester of pregnancy might be more likely to have a child with an atrial septal defect or other congenital heart malformation. Zofran lawsuits are now mounting in U.S. courts that seek compensation for these and other birth defects allegedly associated with use of the anti-nausea medication.
Bernstein Liebhard LLP, a nationwide law firm that represents the victims of serious drug side effects and complications, is investigating legal claims on behalf of children who may be suffering from atrial septal defect because of Zofran. If your baby was exposed to this medication during the first trimester of pregnancy and has been diagnosed with this serious heart abnormality, please call (888) 994-5118 to discuss your legal options with one of our attorneys.
Zofran is manufactured by GlaxoSmithKline and was approved by the U.S. Food & Drug Administration (FDA) in 1991. It is only approved to treat nausea and vomiting related to certain cancer treatments or experienced by people who have just undergone surgery. However, a recent analysis found that the drug has been prescribed to about 1 million women annually to treat nausea and vomiting related to pregnancy, even though its potential impacts on a developing fetus have not been well studied.
In recent years, a number of reports and studies have suggested that children born to women treated with Zofran during the first trimester are more likely to develop a serious birth defect.
An atrial septal defect occurs when a hole forms in the upper 2 chambers of the heart (atria) during fetal development. Symptoms of the condition include:
Patients who are asymptomatic or who have only minor symptoms may not require treatment of an atrial septal defect. Surgery or other intervention to close the hole may be recommended if it causes a large amount of shunting, the heart swells, or other symptoms occur.
Since February 2015, scores of plaintiffs have filed Zofran lawsuits over the drug’s alleged link to birth defects in courts around the U.S. All such federal cases were centralized in a multidistrict litigation currently underway in the U.S. District Court, District of Massachusetts, by an Order of the U.S. Judicial Panel on Multidistrict Litigation dated October 13, 2015. Read More
There is legal help available for children who may have suffered a Zofran atrial septal defect. To discuss your case with an attorney at Bernstein Liebhard LLP, please call (888) 994-5118 today.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.